Insights

Acquisition Opportunity Acceleron is now a wholly-owned subsidiary of Merck, with significant recent M&A activity and a large-scale integration potential. This creates cross-sell opportunities for Merck’s portfolio and potential collaboration with Merck’s commercial and scientific teams to maximize asset value.

PAH Expertise Acceleron’s pulmonary arterial hypertension PAH asset sotatercept positions the company in a high-need niche. There are opportunities to engage for partnership or co-development with firms pursuing advanced PAH therapies or to explore indications where sotatercept's mechanism may be relevant.

First-Line Expansion Recent mentions of BMS/Acceleron plans to expand Reblozyl into first-line MDS suggest a pipeline expansion and market education needs. This signals potential for KOL engagements, payer strategy support, and field resources to drive early adoption and payer coverage.

Financial Scale With an inputs profile of revenue in the tens of millions and a substantial funding base, Acceleron/Merck combination has financial capacity for strategic partnerships, co-funded trials, and expanded manufacturing or CRO collaborations to scale upcoming trials and commercialization.

Tech & Communications The tech stack indicates a modern web and marketing automation footprint (SiteCatalyst, HubSpot, Segment, Drupal/WordPress). This provides an opening for analytics-led marketing services, data integration partnerships, and enhanced digital engagement solutions to accelerate outreach and diagnostics for potential customers or partners.

Similar companies to Acceleron Pharma

Acceleron Pharma Tech Stack

Acceleron Pharma uses 8 technology products and services including SiteCatalyst, Drupal, WordPress, and more. Explore Acceleron Pharma's tech stack below.

  • SiteCatalyst
    Analytics
  • Content Management System
  • Content Management System
  • Customer Data Platforms
  • Font Awesome
    Font Scripts
  • Marketing Automation
  • Real User Monitoring
  • Microsoft ASP.NET
    Web Frameworks

Media & News

Acceleron Pharma's Email Address Formats

Acceleron Pharma uses at least 4 email formats:
Acceleron Pharma Email FormatsExamplePercentage
FLast@acceleronpharma.comJDoe@acceleronpharma.com
91%
First.Last@acceleronpharma.comJohn.Doe@acceleronpharma.com
5%
Last@acceleronpharma.comDoe@acceleronpharma.com
3%
First@acceleronpharma.comJohn@acceleronpharma.com
1%

Frequently Asked Questions

What is Acceleron Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Acceleron Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Acceleron Pharma's stock symbol?

Minus sign iconPlus sign icon
Acceleron Pharma is a publicly traded company; the company's stock symbol is XLRN.

What is Acceleron Pharma's official website and social media links?

Minus sign iconPlus sign icon
Acceleron Pharma's official website is acceleronpharma.com and has social profiles on LinkedIn.

How much revenue does Acceleron Pharma generate?

Minus sign iconPlus sign icon
As of July 2026, Acceleron Pharma's annual revenue is estimated to be $25M - $50M.

What is Acceleron Pharma's SIC code and NAICS code?

Minus sign iconPlus sign icon
Acceleron Pharma's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Acceleron Pharma have currently?

Minus sign iconPlus sign icon
As of July 2026, Acceleron Pharma has approximately 201 employees across 3 continents, including North America, Europe and Asia. Key team members include Vice President Finance: D. P., Vice President And Head Of Technical Operations: M. B. and President: J. H. Explore Acceleron Pharma's employee directory with LeadIQ.

What industry does Acceleron Pharma belong to?

Minus sign iconPlus sign icon
Acceleron Pharma operates in the Biotechnology Research industry.

What technology does Acceleron Pharma use?

Minus sign iconPlus sign icon
Acceleron Pharma's tech stack includes SiteCatalyst, Drupal, WordPress, Segment, Font Awesome, HubSpot, New Relic and Microsoft ASP.NET.

What is Acceleron Pharma's email format?

Minus sign iconPlus sign icon
Acceleron Pharma's email format typically follows the pattern of FLast@acceleronpharma.com. Find more Acceleron Pharma email formats with LeadIQ.

How much funding has Acceleron Pharma raised to date?

Minus sign iconPlus sign icon
As of July 2026, Acceleron Pharma has raised $1.4B in funding. The last funding round occurred on Jun 30, 2020 for $493M.

When was Acceleron Pharma founded?

Minus sign iconPlus sign icon
Acceleron Pharma was founded in 2003.
Acceleron Pharma logo

Acceleron Pharma

Biotechnology ResearchMassachusetts, United States201-500 Employees

Acceleron Pharma is a biotechnology research company based in Cambridge, Massachusetts. It has pursued therapies for pulmonary arterial hypertension, including sotatercept as a central asset in its portfolio. In November 2021, Acceleron became a wholly owned subsidiary of Merck & Co.

As part of Merck, Acceleron's activities sit within broader pulmonary disease therapeutics and biologics research. The organization is mid-sized and employs a few hundred people. A recent development is that Merck gained exclusive rights to sotatercept in the pulmonary hypertension field through the acquisition of Acceleron.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
XLRN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2003
Employees
201-500

Section iconFunding & Financials

  • $1.4B

    Acceleron Pharma has raised a total of $1.4B of funding over 15 rounds. Their latest funding round was raised on Jun 30, 2020 in the amount of $493M as a Post IPO Equity.

  • $25M - $50M

    Acceleron Pharma's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.